Final results from CLN-14 study in STS
November 20, 2013 07:45 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 26-13 / Copenhagen, November 20, 2013
Topotarget announces the final results from the first stage of the phase II part of the phase I/II clinical...
Topotarget announces the financial results for the first 9 months of 2013
November 07, 2013 03:09 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 25-13 / Copenhagen, November 7, 2013
Topotarget announces that the board of directors has reviewed and approved the company’s interim report for the...
Topotarget offentliggør resultat for de første 9 måneder af 2013
November 07, 2013 03:09 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 25-13 / København, 7. november 2013
Topotarget meddeler, at bestyrelsen i dag har behandlet og godkendt selskabets delårsrapport for perioden 1....
Finanskalender 2014
November 01, 2013 05:44 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 24-13 / København, 1. november 2013
Topotarget offentliggør hermed selskabets finanskalender for...
Financial Calendar 2014
November 01, 2013 05:44 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 24-13 / Copenhagen, November 1, 2013
Topotarget announces its financial calendar for 2014 as...
Time and date for teleconference regarding financial results for first 9 months 2013
November 01, 2013 05:04 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News No. 09-13 / Copenhagen, November 1, 2013 Topotarget A/S
Topotarget announces that a teleconference will be held on November 7, 2013 at 1:00 pm...
Tid og dato for telekonference vedrørende resultat for første 9 måneder 2013
November 01, 2013 05:04 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investor Nyhed nr. 09-13 / København, 1. november 2013 Topotarget A/S
Topotarget meddelte i dag, at der vil blive afholdt en telekonference den 7. november 2013...
Topotarget og Spectrum Pharmaceuticals aftaler vilkårene for kommerciel fremstilling af belinostat
October 07, 2013 03:01 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 23-13 / København, 7. oktober 2013
Topotarget og Spectrum Pharmaceuticals offentliggør en ændring til selskabernes eksisterende licensaftale. I...
Topotarget and Spectrum Pharmaceuticals agree on terms for commercial supply of belinostat
October 07, 2013 03:01 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 23-13 / Copenhagen, October 7, 2013
Topotarget and Spectrum Pharmaceuticals announce an amendment to the companies’ existing License Agreement....
Topotarget to present at the 15th Annual Rodman & Renshaw Global Investment Conference
August 30, 2013 08:46 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News No. 08-13 / Copenhagen, August 30, 2013
Topotarget will be presenting at the 15th Annual Rodman & Renshaw Global Investment Conference which is...